Please wait a minute...
Shopping Cart Email List Chinese
Advanced Search Fig/Tab
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Featured Articles  |  Most Downloaded  |  Most Reading
Online Submission Subscribe to Our RSS Content Feed
Front. Med.    2008, Vol. 2 Issue (2) : 139-142    https://doi.org/10.1007/s11684-008-0026-x
Beneficial effects of preventive cholecystectomy in patients with hepatic cancer
LIU Anzhong, LI Jun, HUA Huwei
Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangzhou Medical College
 Download: PDF(57 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract There is no conclusive answer to the question whether excising gall bladder is helpful to the patient with hepatic cancer. The survival rate of patients with hepatic cancer for more than two years has been increased, and the incidence of complications of cholecystitis and gall stone are relatively higher among these patients, which may seriously complicate treatment of advanced hepatic cancer and decrease quality of life. The researchers conducted a prospective clinical investigation from 2002 to 2006 to assess the clinical significance of preventive cholecystectomy in patients with hepatic cancer. One hundred and eighteen cases of postoperative patients with hepatic cancer, who survived for more than two years, were followed up. Based on whether cholecystectomy was performed, the patients were divided into two groups including 48 cases with cholecystectomy and 70 cases with cholecyst reserved. The two-year morbidity of gall stone and morbidity of pain in the right upper abdomen of cholecyst reservation group were 54.29% and 68.57%, respectively, obviously higher than 0.00% and 20.83% of cholecystectomy group. Mainly for those treated with transcatheter arterial chemo-embolization, the morbidity of gall stone was 86.67% (P < 0.01). Therefore, preventive cholecystectomy is strongly recommended during hepatectomy to decrease the incidence of chronic cholecystitis and gall stone, especially for those whose chemotherapy and embolization will be carried out through hepatic artery and portal vein.
Issue Date: 05 June 2008
 Cite this article:   
LI Jun,LIU Anzhong,HUA Huwei. Beneficial effects of preventive cholecystectomy in patients with hepatic cancer[J]. Front. Med., 2008, 2(2): 139-142.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-008-0026-x
https://academic.hep.com.cn/fmd/EN/Y2008/V2/I2/139
1 Kim W R Brown R S Terrault N A El-Serag H Burden of liverdisease in the United States: summary of a workshopHepatology 2002 36(1)227242.
doi:10.1053/jhep.2002.34734
2 Abu Hilal M Lodge J P Pushing back the frontiersof resectability in liver cancer surgeryEur J Surg Oncol 2007 [Epub ahead ofprint]
3 Koffron A J Kung R D Auffenberg G B Abecassis M M Laparoscopicliver surgery for everyone: the hybrid methodSurgery 2007 142(4)463468.
doi:10.1016/j.surg.2007.08.006
4 Koller F L Geevarghese S K Gorden D L Liver transplantation for hepatocellular carcinoma: currentrole and future opportunitiesCurr PharmDes 2007 13(32)32653273.
doi:10.2174/138161207782360591
5 Sugawara Y Tamura S Makuuchi M Living donor liver transplantation for hepatocellular carcinoma:Tokyo University seriesDig Dis 2007 25(4)310312.
doi:10.1159/000106910
6 Lencioni R Crocetti L Radiofrequency ablation ofliver cancerTech Vasc Interv Radiol 2007 10(1)3846.
doi:10.1053/j.tvir.2007.08.006
7 Chen X P Hu D Y Zhang Z W Zhang B X Chen Y F Zhang W G Qiu F Z Role of mesohepatectomy withor without transcatheter arterial chemoembolization for large centrallylocated hepatocellular carcinomaDig Surg 2007 24(3)208213.
doi:10.1159/000102901
8 Miraglia R Pietrosi G Maruzzelli L Petridis I Caruso S Marrone G Mamone G Vizzini G Luca A Gridelli B Predictive factors oftumor response totrans-catheter treatment in cirrhotic patients with hepatocellularcarcinoma: A multivariate analysis of pre-treatment findingsWorld J Gastroenterol 2007 13(45)60226026.
doi:10.3748/wjg.13.6022
9 Gananadha S Yan T D Zhao J Clingan P Glenn D Morris D L Radiologicallyplaced temporary hepatic artery catheter for treatment of liver cancerAustralas Radiol 2005 49(5)396399.
doi:10.1111/j.1440‐1673.2005.01501.x
10 Chavan A Caselitz M Gratz K F Lotz J Kirchhoff T Piso P Wagner S Manns M Galanski M Hepatic arteryembolization for treatment of patients with hereditary hemorrhagictelangiectasia and symptomatic hepatic vascular malformationsEur Radiol 2004 14(11)20792085.
doi:10.1007/s00330‐004‐2455‐5
11 Jiao L R Szyszko T Al-Nahhas A Tait P Canelo R Stamp G Wasan H Lowdell C Philips R Thillainayagam A Bansi D Rubello D Limongelli P Woo K Habib N A Clinical and imaging experiencewith yttrium-90 microspheres in the management of unresectable livertumoursEur J Surg Oncol 2007 33(5)597602.
doi:10.1016/j.ejso.2007.02.021
12 Shimada K Sano T Sakamoto Y Kosuge T A long-term follow-upand management study of hepatocellular carcinoma patients survivingfor 10 years or longer after curative hepatectomyCancer 2005 104(9)19391947.
doi:10.1002/cncr.21461
13 La Greca G Barbagallo F Rodolico M Greco L Randazzo V Scuderi M Russello D Hepatocarcinoma, gallstonedisease and gallbladder carcinoma: a case report of a rare incidentalassociationChir Ital 2004 56(4)571574
14 Dulucq J L Wintringer P Stabilini C Berticelli J Mahajna A Laparoscopic liver resections:a single center experienceSurg Endosc 2005 19(7)886891.
doi:10.1007/s00464‐004‐2044‐3
15 Sung Y M Choi D Lim H K Lee W J Kim S H Kim M J Paik S W Yoo B C Koh K C Lee J H Choi M S Long-termresults of percutaneous ethanol injection for the treatment of hepatocellularcarcinoma in KoreaKorean J Radiol 2006 7(3)187192
16 Akhlaghpoor S Tomasian A Arjmand Shabestari A Ebrahimi M Alinaghizadeh M R Percutaneous osteoid osteomatreatment with combination of radiofrequency and alcohol ablationClin Radiol 2007 62(3)268273.
doi:10.1016/j.crad.2006.08.017
17 Ruers T J Joosten J J Wiering B Langenhoff B S Dekker H M Wobbes T Oyen W J Krabbe P F Punt C J Comparisonbetween local ablative therapy and chemotherapy for non-resectablecolorectal liver metastases: a prospective studyAnn Surg Oncol 2007 14(3)11611169.
doi:10.1245/s10434‐006‐9312‐5
18 Martin R C Scoggins C R McMasters K M Microwave hepatic ablation: initial experience of safetyand efficacyJ Surg Oncol 2007 96(6)481486.
doi:10.1002/jso.20750
19 Arienti V Pretolani S Goldberg S N Silverman S G Gervais D A Lencioni R Sacks D Dupuy D How to report and compare complicationsof image-guided ablation therapies: comments on seeding and the useof a sole common denominator for liver tumorsRadiology 2006 241(2)625626.
doi:10.1148/radiol.2412051962
20 Yoneyama K Miyagishi K Kiuchi Y Shibata M Mitamura K Risk factors for infections in cirrhoticpatients with and without hepatocellular carcinomaJ Gastroenterol 2002 37(12)10281034.
doi:10.1007/s005350200173
21 Dai H Ding H Liu F Yao Z Li L Li C Tan Y Wang J Complicationsof chemoembolization for hepatic neoplasmsSaudi Med J 2007 28(8)12081212
22 Puggioni A Wong L L A metaanalysis of laparoscopiccholecystectomy in patients with cirrhosisJ Am Coll Surg 2003 197(6)921926.
doi:10.1016/j.jamcollsurg.2003.08.011
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed